CDC6 is a possible biomarker for hepatocellular carcinoma
CONCLUSIONS: The expression level of CDC6 in hepatocellular carcinoma is related tightly to clinical findings. Detecting the expression of CDC6 might provide a new biomarker for patients with hepatocellular carcinoma.PMID:34367412 | PMC:PMC8339721
Source: International Journal of Clinical and Experimental Pathology - Category: Pathology Authors: De-Gang Kong Fu-Zhou Yao Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoid Tumor | Carcinoma | Databases & Libraries | Hepatocellular Carcinoma | Liver | Liver Cancer | Melanoma | Pathology | Skin Cancer | Urology & Nephrology